Recalls in the food and beverage industry due to contamination incidents can be catastrophic for a company. Not only do companies have to pay fines and damages, but the impacts on the brand’s reputation can be long-lasting. That’s why Spore.Bio, a Paris-based deeptech startup, is trying to reinvent microbiology testing to get ahead of the next PR crisis in the food industry. The company recently secured a $23 million Series A round, a little more than a year after it raised an €8 million pre-seed round ($8.3 million at current exchange rates). Singular led the round, while Point 72 Ventures, 1st Kind Ventures (the family office of the Peugeot family), Station F and Lord David Prior participated. Returning backers LocalGlobe, No Label Ventures and Famille C also invested. Spore.Bio managed to raise so quickly after its pre-seed round because it’s seeing real customer interest. The startup has already signed a few commercial contracts covering up to 200 factories, and it had to open a waitlist to keep up with demand.

Full report : Paris-based Spore.Bio, which has developed a pre-trained deep learning algorithm to speed up microbiology testing, raised a $23 million Series A led by Singular.